Abbott Laboratories Corporation

Abbvie Inc.

David D Anderson

Curt S Cooper

Rolf Wagner

Christopher E Motter

Todd Warren Rockway

Michael D Tufano

David A Betebenner

Allan C Krueger

Tami J Pilot-Matias

Rong Zhang

Jason P Shanley

Liangjun Lu

Robert J Carrick

Hongmei Mo

Wenping He

Dale J Kempf

Douglas M Kalvin

Darold L Madigan

Mira Hinman

Yu-Gui Gu

Bruce A Beutel

Akhteruzzaman Molla

Sherie V L Masse

Nobuhiko Iwasaki

John K Pratt

Dachun Liu

Clarence J Maring

Keith F McDaniel

Brian E Green

Teresa A Rosenberg

Zhenkun Ma

David A DeGoey

Pamela L Donner

Hong Yong

Xenia Beebe Searle

David J Grampovnik

Moshe Weitzberg

William Sanders

Robert F Keyes

Daniel P Larson

Linda M Lynch

Todd D Bosse

Peter Dandliker

Caroline David

Larry L Klein

Todd M Hansen

Richard F Clark

Ming Clinton Yeung

Hui-Ju J Chen

David A Degoey

Tianyuan Zhang

Fabio Palazzo

Akteruzzaman Molla

Tamara Rehm

Sherie Vl Masse

Weping He

This invention relates to: (a) compounds of formula I and salts thereof that, inter alia, are useful as hepatitis C virus (HCV) inhibitors; (b) intermediates useful for the preparation of such compounds and salts; (c) pharmaceutical compositions comprising such compounds and salts; and (d) methods of use of such compounds, salts, and compositions.

HCV protease inhibitors and uses thereof

Compounds effective in inhibiting replication of Hepatitis C virus ('HCV') or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

Anti-viral compounds

Antibacterials having formula (I) and salts, prodrugs, and salts of prodrugs thereof, processes for making the compounds and intermediates used in the processes, compositions containing the compounds, and methods of prophylaxis and treatment of bacterial infections using the compounds are disclosed.

Antibacterial compounds

Bacterial protein synthesis-inhibiting compounds having formula (I)  and salts, prodrugs, and salts of prodrugs thereof, processes for making the compounds and intermediates in the processes, compositions containing the compounds, and methods of using the compounds are disclosed.

Bacterial protein synthesis-inhibiting compounds having formula (I) and salts, prodrugs, and salts of prodrugs thereof, processes for making the compounds and intermediates in the processes, compositions containing the compounds, and methods of using the compounds are disclosed.

Growing community of inventors

Kenosha, WI, United States of America

David D Anderson